134 related articles for article (PubMed ID: 31626034)
21. [THE BRAF MUTATION AND THE POSSIBILITIES OF UVEAL MELANOMA METASTASING PROGNOSTIC MARKERS IDENTIFICATION].
Horkovičová K; Markus J; Krčová I; Babál P; Kobzová D; Smolková B
Cesk Slov Oftalmol; 2016; 72(4):149-156. PubMed ID: 27860480
[TBL] [Abstract][Full Text] [Related]
22. Chromosome 3 status combined with BAP1 and EIF1AX mutation profiles are associated with metastasis in uveal melanoma.
Ewens KG; Kanetsky PA; Richards-Yutz J; Purrazzella J; Shields CL; Ganguly T; Ganguly A
Invest Ophthalmol Vis Sci; 2014 Jun; 55(8):5160-7. PubMed ID: 24970262
[TBL] [Abstract][Full Text] [Related]
23. The hunt for the secrets of uveal melanoma.
Shields CL
Clin Exp Ophthalmol; 2008 Apr; 36(3):277-80. PubMed ID: 18412599
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and implications of TERT promoter mutation in uveal and conjunctival melanoma and in benign and premalignant conjunctival melanocytic lesions.
Koopmans AE; Ober K; Dubbink HJ; Paridaens D; Naus NC; Belunek S; Krist B; Post E; Zwarthoff EC; de Klein A; Verdijk RM;
Invest Ophthalmol Vis Sci; 2014 Aug; 55(9):6024-30. PubMed ID: 25159205
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the contribution of germline variants in BRCA1 and BRCA2 to uveal and cutaneous melanoma.
Johansson PA; Nathan V; Bourke LM; Palmer JM; Zhang T; Symmons J; Howlie M; Patch AM; Read J; Holland EA; Schmid H; Warrier S; Glasson W; Höiom V; Wadt K; Jönsson G; Olsson H; Ingvar C; Mann G; Brown KM; Hayward NK; Pritchard AL
Melanoma Res; 2019 Oct; 29(5):483-490. PubMed ID: 31464824
[TBL] [Abstract][Full Text] [Related]
26. Germline BAP1-positive patients: the dilemmas of cancer surveillance and a proposed interdisciplinary consensus monitoring strategy.
Star P; Goodwin A; Kapoor R; Conway RM; Long GV; Scolyer RA; Guitera P
Eur J Cancer; 2018 Mar; 92():48-53. PubMed ID: 29413689
[TBL] [Abstract][Full Text] [Related]
27. Familial uveal melanoma. Clinical observations on 56 patients.
Singh AD; Shields CL; De Potter P; Shields JA; Trock B; Cater J; Pastore D
Arch Ophthalmol; 1996 Apr; 114(4):392-9. PubMed ID: 8602775
[TBL] [Abstract][Full Text] [Related]
28. Uveal vs. cutaneous melanoma. Origins and causes of the differences.
Belmar-Lopez C; Mancheno-Corvo P; Saornil MA; Baril P; Vassaux G; Quintanilla M; Martin-Duque P
Clin Transl Oncol; 2008 Mar; 10(3):137-42. PubMed ID: 18321815
[TBL] [Abstract][Full Text] [Related]
29. Positive interaction between light iris color and ultraviolet radiation in relation to the risk of uveal melanoma: a case-control study.
Schmidt-Pokrzywniak A; Jöckel KH; Bornfeld N; Sauerwein W; Stang A
Ophthalmology; 2009 Feb; 116(2):340-8. PubMed ID: 19091418
[TBL] [Abstract][Full Text] [Related]
30. Cutaneous dysplastic naevi in uveal melanoma patients: markers for prognosis?
Tóth-Molnár E; Hammer H; Oláh J
Melanoma Res; 2000 Feb; 10(1):36-9. PubMed ID: 10711638
[TBL] [Abstract][Full Text] [Related]
31. Tissue-specific significance of BAP1 gene mutation in prognostic prediction and molecular taxonomy among different types of cancer.
Wang XY; Wang Z; Huang JB; Ren XD; Ye D; Zhu WW; Qin LX
Tumour Biol; 2017 Jun; 39(6):1010428317699111. PubMed ID: 28618948
[TBL] [Abstract][Full Text] [Related]
32. Clinical and cytogenetic analyses in uveal melanoma.
Kilic E; van Gils W; Lodder E; Beverloo HB; van Til ME; Mooy CM; Paridaens D; de Klein A; Luyten GP
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3703-7. PubMed ID: 16936076
[TBL] [Abstract][Full Text] [Related]
33. Different Pigmentation Risk Loci for High-Risk Monosomy 3 and Low-Risk Disomy 3 Uveal Melanomas.
Mobuchon L; Derrien AC; Houy A; Verrier T; Pierron G; Cassoux N; Milder M; Deleuze JF; Boland A; Scelo G; Cancel-Tassin G; Cussenot O; Rodrigues M; Noirel J; Machiela MJ; Stern MH
J Natl Cancer Inst; 2022 Feb; 114(2):302-309. PubMed ID: 34424336
[TBL] [Abstract][Full Text] [Related]
34. Characterization of melanocortin-1 receptor gene variants in uveal melanoma patients.
Metzelaar-Blok JA; ter Huurne JA; Hurks HM; Keunen JE; Jager MJ; Gruis NA
Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):1951-4. PubMed ID: 11481256
[TBL] [Abstract][Full Text] [Related]
35. Association between choroidal pigmentation and posterior uveal melanoma in a white population.
Harbour JW; Brantley MA; Hollingsworth H; Gordon M
Br J Ophthalmol; 2004 Jan; 88(1):39-43. PubMed ID: 14693770
[TBL] [Abstract][Full Text] [Related]
36. Germline BAP1 alterations in familial uveal melanoma.
Rai K; Pilarski R; Boru G; Rehman M; Saqr AH; Massengill JB; Singh A; Marino MJ; Davidorf FH; Cebulla CM; H Abdel-Rahman M
Genes Chromosomes Cancer; 2017 Feb; 56(2):168-174. PubMed ID: 27718540
[TBL] [Abstract][Full Text] [Related]
37. Expression of Antimicrobial Peptides by Uveal and Cutaneous Melanoma Cells and Investigation of Their Role in Tumor Cell Migration and Vasculogenic Mimicry.
Manarang JC; Otteson DC; McDermott AM
Curr Eye Res; 2017 Nov; 42(11):1474-1481. PubMed ID: 28910167
[TBL] [Abstract][Full Text] [Related]
38. Cytogenetics of uveal melanoma: a 7-year clinical experience.
Damato B; Duke C; Coupland SE; Hiscott P; Smith PA; Campbell I; Douglas A; Howard P
Ophthalmology; 2007 Oct; 114(10):1925-31. PubMed ID: 17719643
[TBL] [Abstract][Full Text] [Related]
39. Metastatic disease in uveal melanoma: importance of a genetic profile?
Van Beek JG; Koopmans AE; Vaarwater J; Verdijk RM; de Klein A; Naus NC; Kiliç E
Melanoma Res; 2015 Oct; 25(5):447-9. PubMed ID: 26086698
[TBL] [Abstract][Full Text] [Related]
40. Genomic investigations of posterior uveal melanoma.
Hovland PG; Trempe C
Semin Ophthalmol; 2005; 20(4):231-8. PubMed ID: 16352494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]